Orchestra BioMed (OBIO) Tops Q3 EPS by 4c

Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.38), $0.04 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $420 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.

You May Also Be Interested In

• Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
• Global-e Online (GLBE) Tops Q2 EPS by 16c ; Offers Guidance
• PagSeguro Digital Ltd. (PAGS) Misses Q2 EPS by 2c